Topics
April 2014 | Editor's Message
A Bittersweet Sign Off
Rachel Renshaw, Editor-in-Chief
April 16, 2026
Experimental Light-Activated Therapy Shows Early Promise for Retinitis Pigmentosa
April 15, 2026
Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply for Ophthalmic Program
April 14, 2026
Smoking Doubles Risk of Major Eye Diseases, Global Study Finds
OnPoint Vision Expands Clinical Trial for Investigational Lens Targeting AMD Patients
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar
